[
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 10633,
  "as_at": "2025-06-08",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "On 8 June 2025, there were 10,633 adults waiting for neurodevelopmental assessment."
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "referrals_12m",
  "value": 3722,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025 there were 3,722 referrals for adult neurodevelopmental assessment."
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "assessments_12m",
  "value": 718,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025, NHS Lothian carried out 718 adult neurodevelopmental assessments."
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "average_wait_weeks",
  "value": 97,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025, the average waiting time for completed adult neurodevelopmental assessment was 97 weeks."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 9643,
  "as_at": "2025-06-08",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "On 8 June 2025, there were 9,643 children and young people waiting for neurodevelopmental assessment."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "referrals_12m",
  "value": 4133,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025 there were 4,133 referrals for children and young people's neurodevelopmental assessment."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "assessments_12m",
  "value": 616,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025, NHS Lothian carried out 616 children and young people's neurodevelopmental assessments."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "average_wait_weeks",
  "value": 86,
  "as_at": "2025-03-30",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "In the 12 months between 1 April 2024 and 30 March 2025, the average waiting time for completed children's and young people's neurodevelopmental assessment was 86 weeks."
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "No separate ADHD or ASD referral pathway; all patients referred for a single 'neurodevelopmental assessment'.",
  "as_at": "2025-06-08",
  "source_title": "NHS Lothian FOI response 10175 (ADHD/Autism/Neurodevelopmental Assessment)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "There is not a separate referral pathway for adult ASD assessment in NHS Lothian. Patients are referred for neurodevelopmental assessment."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "No separate ADHD/ASD waiting lists; all patients on non-specific 'Neurodevelopmental Assessment' lists.",
  "as_at": "2026-06-24",
  "source_title": "NHS Lothian FOI response 11541 (ADHD and Autism Assessments)",
  "source_url": "https://org.nhslothian.scot/FOI",
  "source_type": "foi",
  "quote": "For children and young people, there are no ADHD / ASD specific waiting lists. All patients are on non-specific \"Neurodevelopmental Assessment\" lists. We are therefore unable to provide an accurate figure for wait times to assessment or number of children currently waiting specifically for an ADHD, ASD assessment."
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "referrals_12m",
  "value": 728,
  "as_at": "2025-03-31",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "The following figures are for all child neurodevelopmental conditions... 2024/25: 728"
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "percentile90_wait_weeks",
  "value": 177,
  "as_at": "2025-03-31",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "Below is based on 90th percentile wait for new appointments within target time period, i.e. 9 out of 10 children waited this length of time or shorter. 2024/25: 177 weeks"
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "percentile90_wait_weeks",
  "value": 210,
  "as_at": "2026-02-05",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "2025/26: 210 weeks (data up to and including 5/2/26)"
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "referrals_12m",
  "value": 439,
  "as_at": "2024-12-31",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "Referral rates for Tayside Adult Autism Consultancy Team (TAACT): 2024 – 439"
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "referrals_12m",
  "value": 508,
  "as_at": "2025-12-31",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "Referral rates for Tayside Adult Autism Consultancy Team (TAACT): ... 2025 – 508"
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "number_waiting",
  "value": 761,
  "as_at": "2026-02-26",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "For the Primary Care waiting list there are 761 waiting. The next patient to be appointed was referred in Jan 2022. This is a wait of 213 weeks."
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "longest_wait_weeks",
  "value": 213,
  "as_at": "2026-02-26",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "The longest wait across the service in weeks is 213."
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "number_waiting",
  "value": 119,
  "as_at": "2026-02-26",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "For the Complex Waiting List there are 119 patients waiting. The next patient to be appointed was referred in July 2024. This is 147 weeks."
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "pathway_status",
  "value": "No dedicated ADHD assessment pathway; adult referrals go to generic Community Mental Health Teams and cannot be tracked by condition.",
  "as_at": "2026-02-26",
  "source_title": "NHS Tayside FOI IGTFOISA26067 (GP Referrals and Waiting Times for ADHD and Autism)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_394351&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "Referrals for adults suspected of having ADHD are made to Community Mental Health Teams (CMHTs)... there is no way of reliably reporting the number of referrals for different clinical conditions."
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "adhd",
  "measure": "pathway_status",
  "value": "No ADHD-specific CAMHS pathway; not held in a central/reportable format.",
  "as_at": "2026-05-25",
  "source_title": "NHS Tayside FOI IGTFOISA26389 (CAMHS ADHD Waiting Times)",
  "source_url": "http://www.nhstaysidecdn.scot.nhs.uk/NHSTaysideWeb/idcplg?IdcService=GET_SECURE_FILE&dDocName=PROD_396701&Rendition=web&RevisionSelectionMethod=LatestReleased&noSaveAs=1",
  "source_type": "foi",
  "quote": "NHS Tayside CAMHS do not have an ADHD specific pathway and therefore the information requested is not held in a central location or readily available format."
 },
 {
  "board": "NHS Orkney",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 191,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "As of May 2025, there were 191 children in Orkney awaiting a neurodevelopmental assessment."
 },
 {
  "board": "NHS Orkney",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "average_wait_weeks",
  "value": 108,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "The average wait was 108 weeks, and the longest wait was five years."
 },
 {
  "board": "NHS Orkney",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "longest_wait_weeks",
  "value": 260,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "The average wait was 108 weeks, and the longest wait was five years. (five years converted to 260 weeks)"
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 125,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "As of May 2025, there were 125 adults in Orkney awaiting assessment. That number has consistently risen over the last four years with only 26 adults requiring assessment in 2021."
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "average_wait_weeks",
  "value": 24,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "The current average wait for an adult assessment is 24 weeks with the longest wait being 80 weeks."
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "longest_wait_weeks",
  "value": 80,
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "The current average wait for an adult assessment is 24 weeks with the longest wait being 80 weeks."
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "No local specialist adult ND service; assessments spot-purchased from an external provider.",
  "as_at": "2025-05-31",
  "source_title": "Orkney IJB report: Neurodevelopmental Provision (2 July 2025)",
  "source_url": "https://www.ohb.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "In recent years, assessments have been spot-purchased by NHS Orkney from an external provider. The reason for this arrangement was predominantly due to having no specialist resource locally... spent approximately £300,000 on commissioning of assessments in 2024/25."
 },
 {
  "board": "NHS Orkney",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Neurodevelopmental (CAMHS) activity is included within the CAMHS waiting-times submission, i.e. not reported as a separate pathway.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "NHS Orkney include CAMHS ND activity within their submission."
 },
 {
  "board": "NHS Highland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 1800,
  "as_at": "2024-11-29",
  "source_title": "NHS Highland/Highland Council Joint Monitoring Committee report JMC-21-24: Neuro-Development Assessment Service Programme Board Update",
  "source_url": "https://www.nhshighland.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "There are currently > 1800 children and young people on the NDAS waitlist, of those 959 are unvetted.",
  "qualifier": "minimum"
 },
 {
  "board": "NHS Highland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "average_wait_weeks",
  "value": 84.9,
  "as_at": "2024-11-29",
  "source_title": "NHS Highland/Highland Council Joint Monitoring Committee report JMC-21-24: Neuro-Development Assessment Service Programme Board Update",
  "source_url": "https://www.nhshighland.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "The current average wait is 594 days, with some young people waiting in excess of four years (594 days converted to approximately 84.9 weeks)."
 },
 {
  "board": "NHS Highland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Dedicated Neuro-Development Assessment Service (NDAS), separate from CAMHS, run jointly by NHS Highland and The Highland Council; waitlist described as unsustainable.",
  "as_at": "2024-12-02",
  "source_title": "NHS Highland/Highland Council Joint Monitoring Committee report JMC-21-24: Neuro-Development Assessment Service Programme Board Update",
  "source_url": "https://www.nhshighland.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "An integrated Neuro-Development Assessment Service (NDAS) programme board has been established with representation from NHS Highland, The Highland Council, and 3rd sector partners, in response to both the increasing waiting list for NDAS... The extended waitlist is unsustainable, creating both immediate and long-term challenges with the demand on the service outstripping capacity."
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "autism",
  "measure": "average_wait_weeks",
  "value": 35,
  "as_at": "2018",
  "source_title": "NHS Borders FOI response 622-18 (autism waiting times for children)",
  "source_url": "https://www.borders.scot.nhs.uk",
  "source_type": "foi",
  "quote": "The average current time from referral to diagnosis is 35 weeks; this includes the full multidisciplinary assessment process, involving assessments in a classroom setting, interviews with parents and teachers and observation of the child by a range of different professional staff.",
  "date_inferred": true
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "autism",
  "measure": "number_waiting",
  "value": 65,
  "as_at": "2018",
  "source_title": "NHS Borders FOI response 622-18 (autism waiting times for children)",
  "source_url": "https://www.borders.scot.nhs.uk",
  "source_type": "foi",
  "quote": "There are 65 children awaiting diagnosis, 62 new and 3 reviews.",
  "date_inferred": true
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "No alternative pathway to CAMHS for neurodevelopmental assessment/diagnosis; whole-systems review proposed in 2024 to change this.",
  "as_at": "2024-07-10",
  "source_title": "NHS Borders Strategic Planning Group report: Neurodevelopmental Service Whole Systems Approach Proposal",
  "source_url": "https://www.borders.scot.nhs.uk",
  "source_type": "committee_paper",
  "quote": "Neurodivergence is not a mental illness, but the current clinical expertise sits predominantly within the CAMHS requiring referrals to CAMHS for assessment and diagnosis. There are no other alternative pathways at present."
 },
 {
  "board": "NHS Grampian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Aberdeenshire: adult Autism and ADHD diagnostic pathway ceased 31 March 2025; waiting list closed and clients contacted to be informed.",
  "as_at": "2025-03-31",
  "source_title": "Aberdeenshire IJB report (19 Jan 2026): Response to request to explore a reduced Neurodevelopmental Assessment Pathway",
  "source_url": "https://www.aberdeenshire.gov.uk",
  "source_type": "committee_paper",
  "quote": "Note that as of 31 March 2025 the diagnostic pathway for Adult Autism and ADHD (Attention Deficit-hyperactivity Disorder) assessment ceased, as agreed at the IJB meeting on the 19 February 2025."
 },
 {
  "board": "NHS Grampian",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "pathway_status",
  "value": "Aberdeen City: small dedicated adult ADHD assessment pathway available (separate from Autism).",
  "as_at": "2025-06-01",
  "source_title": "Aberdeenshire IJB report (19 Jan 2026)",
  "source_url": "https://www.aberdeenshire.gov.uk",
  "source_type": "committee_paper",
  "quote": "Within NHS Grampian, both Autism and ADHD assessment pathways are available in Aberdeen City, although this is a relatively small provision. Funding for these services became available following a review of mental health services in Aberdeen City."
 },
 {
  "board": "NHS Grampian",
  "cohort": "adult",
  "condition": "autism",
  "measure": "pathway_status",
  "value": "Moray: autism-only adult assessment pathway, staffed two mornings a week; no ADHD pathway.",
  "as_at": "2025-06-01",
  "source_title": "Aberdeenshire IJB report (19 Jan 2026)",
  "source_url": "https://www.aberdeenshire.gov.uk",
  "source_type": "committee_paper",
  "quote": "In Moray, there is currently only an autism assessment pathway, supported by a staff member being released to join the Adult Autism Assessment Team operating two mornings a week."
 },
 {
  "board": "NHS Grampian",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity excluded from CAMHS reporting unless it meets CAMHS criteria; a cross-system Grampian Neurodevelopmental service is still in development.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "NHS Grampian follow the Scottish Government CAMHS National Service Specification and National Neurodevelopmental Specification... There is ongoing work locally around development of a cross systems specific Neurodevelopmental service."
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity excluded from CAMHS waiting-times reporting; CYP with ND-only presentations are referred onward to a separate ND team.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "Activity excluded however included in the referral data as neuro diverse presentations can't always be defined at point of referral. Any mental health issues/problems will be addressed during the generic assessment and then an onward referral will be made to the Neurodevelopmental team."
 },
 {
  "board": "NHS Dumfries and Galloway",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "CYP referred for ND concerns are declined by CAMHS and forwarded to a separate ND service; ADHD patients are partially included in CAMHS waiting-time figures because they cannot be reliably distinguished.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "CYP are declined from CAMHS referrals and forwarded to the ND service, some are included as no way to differentiate. ADHD patients are included in the waiting times"
 },
 {
  "board": "NHS Fife",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity not included in CAMHS waiting-times reporting; referrals are signposted at screening stage and not added to a CAMHS waiting list.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "NHS Fife have advised us they do not include ND activity in the submission with those referrals signposted at screening and not added to the waiting list."
 },
 {
  "board": "NHS Forth Valley",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity excluded from CAMHS submission since June 2021; open-case and return-appointment data still include CYP with ND difficulties who don't meet CAMHS referral criteria.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "NHS Forth Valley have advised that they included ND activity in the submission up to May 2021. These cases are now excluded from the referral figures submitted."
 },
 {
  "board": "NHS Greater Glasgow and Clyde",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "CYP with ND-only concerns realigned to a new, dedicated ND pathway; not included in CAMHS reporting from April 2024, with an interim referral-redirection process introduced from 1 February 2025.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "NHS Greater Glasgow and Clyde continue to realign children presenting with Neurodevelopmental (ND) concerns only to the new ND pathway... From 1st February 2025, referrals are added to CAMHS and, if deemed ND only, the referral is rejected and redirected to the ND pathway."
 },
 {
  "board": "NHS Lanarkshire",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Dedicated ND service since referral-pathway improvements in October 2022; CYP referred specifically for an NDD assessment go straight to the ND service, not the CAMHS waiting list, though they retain access to the CAMHS Duty team.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "Since the board improved the referral pathways for CAMHS and the ND service in October 2022, CYP who are referred specifically for a NDD assessment, or where NDD is the presenting issue, are directed to the ND service and not placed on the CAMHS waiting list."
 },
 {
  "board": "NHS Shetland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity excluded from CAMHS reporting; included in referrals but removed if the child is transferred to paediatrics for ND assessment.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "The board do not include ND activity however they are included in the referrals and are removed if they are transferred to paediatrics for ND assessment. CAMHS will assess for ND if the young person has a co-existing mental health condition."
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND cases reported separately from CAMHS mental-health cases since April 2019, via an external paediatric neurodevelopmental waiting list.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "From April 2019 NHS Tayside started reporting ND cases separately from CAMHS mental health cases. Comparisons to the data prior to this data should be made with caution."
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "pathway_status",
  "value": "Only an adult autism assessment pathway (TAACT) is available; no dedicated adult ADHD pathway (per June 2025 SPICe briefing, cited secondhand).",
  "as_at": "2025-06-01",
  "source_title": "Aberdeenshire IJB report (19 Jan 2026), citing SPICe briefing 'Neurodevelopmental Pathways and Waiting Times in Scotland' (June 2025)",
  "source_url": "https://www.aberdeenshire.gov.uk",
  "source_type": "committee_paper",
  "quote": "As at June 2025, eight health boards provided an adult neurodevelopmental assessment pathway, however within Tayside and Western Isles only an autism assessment pathway was available."
 },
 {
  "board": "NHS Western Isles",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "ND activity excluded from CAMHS reporting; CYP are seen for an initial appointment and then discharged with onward referral to the appropriate service.",
  "as_at": "2026-06-02",
  "source_title": "PHS: Child and Adolescent Mental Health Services Waiting Times in NHS Scotland – Data Quality document (quarter ending March 2026)",
  "source_url": "https://publichealthscotland.scot/publications/",
  "source_type": "official_statistics",
  "quote": "The board have advised us they do not include ND activity in the submission, however they are included in referrals, seen for an initial appointment, and then discharged with onward referral to appropriate service."
 },
 {
  "board": "NHS Western Isles",
  "cohort": "adult",
  "condition": "autism",
  "measure": "pathway_status",
  "value": "Only an adult autism assessment pathway is available; no dedicated adult ADHD pathway (per June 2025 SPICe briefing, cited secondhand).",
  "as_at": "2025-06-01",
  "source_title": "Aberdeenshire IJB report (19 Jan 2026), citing SPICe briefing 'Neurodevelopmental Pathways and Waiting Times in Scotland' (June 2025)",
  "source_url": "https://www.aberdeenshire.gov.uk",
  "source_type": "committee_paper",
  "quote": "As at June 2025, eight health boards provided an adult neurodevelopmental assessment pathway, however within Tayside and Western Isles only an autism assessment pathway was available."
 },
 {
  "board": "Scotland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 42530,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "The data show that there were 42,530 children waiting for a neurodevelopmental assessment. This amounts to approximately one in twenty-five children aged 0-18, based on 2023 population estimates."
 },
 {
  "board": "Scotland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "number_waiting",
  "value": 23339,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "There were 23,339 adults reported as waiting for a neurodevelopmental assessment as of March 2025, and over 97% of these were in areas where adults did not have to meet the criteria for referral to secondary mental health services to access the services."
 },
 {
  "board": "Scotland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "waiting_2020",
  "value": 2475,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "the number of children waiting for a neurodevelopmental assessment in Ayrshire and Arran, Fife, Lothian and Tayside increased from 2,475 to 14,943 between 2020 and 2025 - an increase of over 500%."
 },
 {
  "board": "Scotland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "waiting_2025",
  "value": 14943,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "the number of children waiting for a neurodevelopmental assessment in Ayrshire and Arran, Fife, Lothian and Tayside increased from 2,475 to 14,943 between 2020 and 2025 - an increase of over 500%."
 },
 {
  "board": "Scotland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "waiting_2020",
  "value": 543,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "the number of adults waiting for a neurodevelopmental assessment in Forth Valley, Highland, Lothian and the Western Isles increased from 543 to 12,974 between 2020 and 2025 - a total increase of over 2200%."
 },
 {
  "board": "Scotland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "waiting_2025",
  "value": 12974,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "the number of adults waiting for a neurodevelopmental assessment in Forth Valley, Highland, Lothian and the Western Isles increased from 543 to 12,974 between 2020 and 2025 - a total increase of over 2200%."
 },
 {
  "board": "Scotland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "mean_of_board_medians_weeks",
  "value": 76,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 22 weeks (NHS Western Isles) and 141 weeks (NHS Ayrshire and Arran), with an average median waiting time of 76 weeks."
 },
 {
  "board": "Scotland",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "mean_of_board_longest_weeks",
  "value": 196,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 69 weeks (NHS Fife) and 342 weeks (NHS Ayrshire and Arran), with an average longest waiting time of 196 weeks."
 },
 {
  "board": "Scotland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "mean_of_board_medians_weeks",
  "value": 76,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 24 weeks (NHS Orkney) and 146 weeks (NHS Tayside), with an average median waiting time of 76 weeks."
 },
 {
  "board": "Scotland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "mean_of_board_longest_weeks",
  "value": 182,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 61 weeks (NHS Fife) and 390 weeks (NHS Greater Glasgow and Clyde), with an average longest waiting time of 182 weeks."
 },
 {
  "board": "NHS Western Isles",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "median_wait_weeks",
  "value": 22,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 22 weeks (NHS Western Isles) and 141 weeks (NHS Ayrshire and Arran)"
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "median_wait_weeks",
  "value": 141,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 22 weeks (NHS Western Isles) and 141 weeks (NHS Ayrshire and Arran)"
 },
 {
  "board": "NHS Fife",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "longest_wait_weeks",
  "value": 69,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 69 weeks (NHS Fife) and 342 weeks (NHS Ayrshire and Arran)"
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "neurodevelopmental_combined",
  "measure": "longest_wait_weeks",
  "value": 342,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 69 weeks (NHS Fife) and 342 weeks (NHS Ayrshire and Arran)"
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "median_wait_weeks",
  "value": 24,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 24 weeks (NHS Orkney) and 146 weeks (NHS Tayside)"
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "autism",
  "measure": "median_wait_weeks",
  "value": 146,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Median waiting times ranged between 24 weeks (NHS Orkney) and 146 weeks (NHS Tayside). ... For NHS Tayside, NHS Forth Valley and NHS Fife, only data for autism assessments is available."
 },
 {
  "board": "NHS Fife",
  "cohort": "adult",
  "condition": "autism",
  "measure": "longest_wait_weeks",
  "value": 61,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 61 weeks (NHS Fife) and 390 weeks (NHS Greater Glasgow and Clyde). ... For NHS Tayside, NHS Forth Valley and NHS Fife, only data for autism assessments is available."
 },
 {
  "board": "NHS Greater Glasgow and Clyde",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "longest_wait_weeks",
  "value": 390,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Longest waiting times ranged between 61 weeks (NHS Fife) and 390 weeks (NHS Greater Glasgow and Clyde)"
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 114,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 32,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 62,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 4,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 3,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Borders",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 6,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Grampian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 75,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Grampian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 15,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Grampian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 22,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 722,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 72,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Lothian",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 205,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 257,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Tayside",
  "cohort": "child",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 148,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Six health boards (Ayrshire and Arran, Borders, Forth Valley, Grampian, Lothian and Tayside) operate waiting lists for ADHD medication for children. Five of these (all except for Forth Valley) reported the number of children on the waiting list, and the median and longest waiting times."
 },
 {
  "board": "NHS Forth Valley",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 24,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases.",
  "partial_coverage": "Clackmannanshire and Stirling only"
 },
 {
  "board": "NHS Highland",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 174,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases."
 },
 {
  "board": "NHS Highland",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 30,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases."
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 410,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases.",
  "partial_coverage": "East Lothian, Midlothian and Edinburgh City only"
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 41,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases.",
  "partial_coverage": "East Lothian, Midlothian and Edinburgh City only"
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 222,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases.",
  "partial_coverage": "East Lothian, Midlothian and Edinburgh City only"
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_number_waiting",
  "value": 71,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases."
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_median_wait_weeks",
  "value": 48,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases."
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "adhd",
  "measure": "medication_longest_wait_weeks",
  "value": 112,
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "For adults, four health boards reported operating waiting lists for medication, although these were not in operation in all Health and Social Care Partnerships (HSCPs) in some cases."
 },
 {
  "board": "NHS Greater Glasgow and Clyde",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "The Adult Autism Team (AAT) operates within the Community Mental Health Teams, and provides autism assessments for adults who do not meet the criteria for referral to secondary mental health services. ADHD assessments are carried out within the HSCPs, rather than through a centralised service, and a different screening process and waiting list is operated in each of the six HSCPs in the Greater Glasgow and Clyde region.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults"
 },
 {
  "board": "NHS Lanarkshire",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Adults in NHS Lanarkshire have access to the Adult Neurodevelopmental Service (ANDS), established in April 2024. ... Despite its name, this service focuses mostly on autism assessment ... It is unclear whether a patient who does not meet the criteria for referral to secondary mental health services can be referred for an ADHD diagnosis in NHS Lanarkshire.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults"
 },
 {
  "board": "NHS Lothian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "For adults, there is an overarching neurodevelopmental pathway within the Community Mental Health Team, although the four HSCPs have different modes of delivery. ... The CMHTs provide neurodevelopmental assessments even if the patient does not meet the criteria for referral to secondary mental health services.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults"
 },
 {
  "board": "NHS Tayside",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "there is no overarching neurodevelopmental pathway for adults in this region. Instead, adults are seen by different teams, depending on whether they require an assessment for ADHD or autism. ADHD referrals are made to Community Mental Health Teams (CMHTs), although for such a referral to be made, the patient must meet the criteria for referral to secondary mental health services. ... the majority of autism assessments are carried out by the Tayside Adult Autism Consultancy Team (TAACT).",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults, autism only"
 },
 {
  "board": "NHS Highland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Neurodivergent adults in NHS Highland have access to separate autism and ADHD pathways. ... As of October 2023, the [ADHD] pathway was not taking any new referrals due to the backlog of existing referrals, and any new patients seeking an ADHD assessment had to meet the criteria for referral to secondary mental health services in order to obtain an assessment. ... The adult autism pathway is independent of the CMHTs and therefore does not require a co-occurring mental health condition to access.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults"
 },
 {
  "board": "NHS Western Isles",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "At present, it operates an adult neurodevelopmental assessment service, although currently ADHD assessment has not been incorporated into this service.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "open to all adults, autism only"
 },
 {
  "board": "NHS Grampian",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Until March 2025, neurodivergent adults who did not meet these criteria were assessed by the Grampian-wide Adult Autism Assessment Team (AAAT). ... in February 2025, Aberdeenshire HSCP announced that ... it would no longer be a part of this program. The AAAT continues to operate in Moray and Aberdeen City. ... For patients seeking an ADHD assessment, Aberdeen City HSCP currently has a small multidisciplinary ADHD assessment service that has been running since 2024. Aberdeenshire HSCP also had an ADHD pathway, but this also ceased due to lack of funding in March 2025.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "varies by partnership"
 },
 {
  "board": "NHS Orkney",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "While a neurodevelopmental pathway for adults is under development in Orkney at present, adult neurodevelopmental assessments are currently outsourced to an external specialist service (Connect to Autism). There is no formal support pathway for adults waiting for these assessments.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "outsourced, pathway under development"
 },
 {
  "board": "NHS Shetland",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "At present, there is an Adult Autism Assessment Pathway in Shetland, to which GPs and other Mental Health Professionals can refer patients. The SLT service manage this pathway, although due to the temporary nature of the funding, assessments are currently on hold.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025.",
  "open_access": "pathway paused"
 },
 {
  "board": "NHS Forth Valley",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "The Adult Autism Assessment Team (AAAT), which delivered neurodevelopmental assessments to adults who do not meet the criteria for referral to secondary mental health services in NHS Forth Valley, was halted in March 2025. The team consisted of just one nurse and one part-time (10%) psychiatrist, and both left their posts in late 2024. ... As a result, neurodevelopmental assessments are only currently available to adults if they meet the criteria for secondary care mental health services, through CMHTs.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025."
 },
 {
  "board": "NHS Borders",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "Adults with co-existing mental health conditions can be referred by their GP for a neurodevelopmental assessment, which is carried out by Community Mental Health Teams. However, this service is only accessible to adults who meet the criteria for referral to secondary mental health services. Adults who do not meet this criteria are given a self-help resource pack and discharged without referral.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025."
 },
 {
  "board": "NHS Fife",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "NHS Fife does not have a specific adult neurodevelopmental pathway. The Community Mental Health Team triage referrals on an individual basis, although assessments are only available for those that meet the criteria for referral to secondary mental health services.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025."
 },
 {
  "board": "NHS Dumfries and Galloway",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "NHS Dumfries and Galloway does not provide neurodevelopmental assessments for adults unless they meet the criteria for referral to secondary mental health services.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025."
 },
 {
  "board": "NHS Ayrshire and Arran",
  "cohort": "adult",
  "condition": "neurodevelopmental_combined",
  "measure": "pathway_status",
  "value": "NHS Ayrshire and Arran have no functioning operational pathway for adult neurodevelopmental assessments, and no longer accept referrals.",
  "source_title": "SPICe Briefing SB 25-25, Neurodevelopmental Pathways and Waiting Times in Scotland",
  "source_url": "https://www.parliament.scot/chamber-and-committees/research-prepared-for-parliament/research-briefings/2025/6/24/sb-2525",
  "source_type": "parliamentary_briefing",
  "as_at": "2025-03-31",
  "quote": "Health boards reported that a neurodevelopmental pathway was available to adults who did not meet the criteria for referral to secondary mental health services in six health boards (Greater Glasgow and Clyde, Lanarkshire, Lothian, Tayside, Highland and Western Isles), although in Tayside and Western Isles this was for autism only. In NHS Grampian, the provision was different across the three Health and Social Care Partnerships (HSCPs) since Aberdeenshire HSCP ceased its adult neurodevelopmental pathway in February 2025."
 }
]